University, private hospitals to have access to Hep C treatment

KUALA LUMPUR: University and private hospitals will soon have access to more affordable Hepatitis C treatment now that the registration of the first Hepatitis C generic drug under voluntary licensing (VL) has been approved.

Currently, the drug is only available in the Health Ministry’s government hospitals, made possible after the government applied the compulsory licence (CL) of the World Trade Organisation’s Agreement on Trade-Related Aspects of Intellectual Property Rights in September 2017 to gain access to the affordable drug.